This trial is studying the standardization of lymph node dissection in ICC.
1 Primary · 3 Secondary · Reporting Duration: 3 years after surgery
Active Control
Experimental Treatment
168 Total Participants · 2 Treatment Groups
Primary Treatment: Extend LymphAdenectomy · No Placebo Group · N/A
Age 18 - 80 · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: